Related Experiment Video

Updated: May 16, 2026

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

MicroRNA let-7a ameliorates con A-induced hepatitis by inhibiting IL-6-dependent Th17 cell differentiation

Yingying Zhang1, Xiangmin Wang, Min Zhong

  • 1Laboratory of Medicine of Yijishan Hospital, Wannan Medical College, Wuhu, 241001, People's Republic of China.

Journal of Clinical Immunology
|November 28, 2012
PubMed

Insights

MicroRNA let-7a shows therapeutic potential for immune-mediated hepatitis by reducing inflammatory responses. This study found let-7a therapy decreased Th17 cells and increased regulatory T cells, offering a novel treatment strategy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Hepatology

Background:

  • Concanavalin A (Con A)-induced hepatitis is an immune-mediated liver disease.
  • Interleukin-6 (IL-6) and Interleukin-17 (IL-17) expression are upregulated in Con A-induced hepatitis.
  • The role of microRNA let-7a in this condition is not fully understood.

Purpose of the Study:

  • To investigate the effects of microRNA let-7a on Con A-induced hepatitis.
  • To elucidate the underlying mechanisms of let-7a's action.
  • To evaluate let-7a as a potential therapeutic strategy.

Main Methods:

  • Mice were treated with a lentiviral vector containing let-7a prior to Con A administration.
  • Liver tissues and serum were analyzed for immune cell populations and cytokine levels.
  • Gene expression analysis was performed for Th17 lineage-specific genes.

Main Results:

  • let-7a treatment significantly reduced Th17 cell frequency and increased regulatory T cell frequency in the liver.
  • Serum levels of inflammatory cytokines (TNF-α, IL-6, IFN-γ) were decreased.
  • let-7a inhibited Th17 differentiation by downregulating IL-6 secretion, affecting genes like Il17a, Il17f, Il21, and Il23r.

Conclusions:

  • MicroRNA let-7a demonstrates a therapeutic effect on Con A-induced hepatitis.
  • let-7a modulates immune responses by reducing Th17 cells and enhancing regulatory T cells.
  • let-7a represents a promising novel therapeutic strategy for immune-mediated inflammatory hepatitis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...